Cargando…
New and Future Drug Development for Gastroesophageal Reflux Disease
Medical therapy remains the most popular treatment for gastroesophageal reflux disease (GERD). Whilst interest in drug development for GERD has declined over the last few years primarily due to the conversion of most proton pump inhibitor (PPI)'s to generic and over the counter compounds, there...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Neurogastroenterology and Motility
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895610/ https://www.ncbi.nlm.nih.gov/pubmed/24466441 http://dx.doi.org/10.5056/jnm.2014.20.1.6 |